Intervention
In the previous (2010-2016) cohort, doxorubicin was used in the induction therapy (6 weeks). It was dropped in the current cohort (2017-2020) from the induction phase once the L-asparaginase supply was consistent. The patients received a three-drug induction (vincristine, prednisone, and L-asparaginase) lasting six weeks. Additionally, patients who did not have health insurance (NHIF) were supported to enroll and transport assistance for needy parents through collaboration with philanthropic organizations and continuous parental counseling and support groups. The social work department facilitated this. Supportive care included better availability and early initiation of antibiotics during episodes of febrile neutropenia and enhanced availability of blood products.